This article is part of the supplement: Severe community-acquired pneumonia update: mortality, mechanisms and medical intervention
Beyond antibiotics in severe community-acquired pneumonia: the role and rationale for tissue factor pathway inhibition
-
Correspondence: Pierre-Francois Laterre Pierre-Francois.Laterre@uclouvain.be
Critical Care 2008, 12(Suppl 6):S4 doi:10.1186/cc7027
No comments have yet been made on this article.